The outbreak of Coronavirus has spread between people around the world at a rapid rate so that the number of infected people and deaths is increasing quickly every day. Accordingly, it is a vital process to detect positive cases at an early stage for treatment and controlling the disease from spreading. Several medical tests had been applied for COVID-19 detection in certain injuries, but with limited efficiency. In this study, a new COVID-19 diagnosis strategy called Feature Correlated Naïve Bayes (FCNB) has been introduced. The FCNB consists of four phases, which are; Feature Selection Phase (FSP), Feature Clustering Phase (FCP), Master Feature Weighting Phase (MFWP), and Feature Correlated Naïve Bayes Phase (FCNBP). The FSP selects only the most effective features among the extracted features from laboratory tests for both COVID-19 patients and non-COVID-19 people by using the Genetic Algorithm as a wrapper method. The FCP constructs many clusters of features based on the selected features from FSP by using a novel clustering technique. These clusters of features are called Master Features (MFs) in which each MF contains a set of dependent features. The MFWP assigns a weight value to each MF by using a new weight calculation method. The FCNBP is used to classify patients based on the weighted Naïve Bayes algorithm with many modifications as the correlation between features. The proposed FCNB strategy has been compared to recent competitive techniques. Experimental results have proven the effectiveness of the FCNB strategy in which it outperforms recent competitive techniques because it achieves the maximum (99%) detection accuracy.
Unfortunately, Covid-19 has infected millions of people very quickly, and it continues to infect people and spreads rapidly. Although there are some common symptoms of Covid-19, its effect varies from one individual to another. Estimating the severity of the infection has become a critical need as it can guide the decision makers to take an accurate and timely response. It will be valuable to provide early warning before infection takes place about susceptibility to the disease, especially since the lack of symptoms is a feature of the Covid-19 pandemic. Asymptomatic patients are considered as “silent diffusers” of the virus; hence, detecting people who will be asymptomatic before actual infection takes place will certainly safe the society from the uncontrolled and unseen spread of the virus. People can be classified based on their vulnerability to Covid-19 even before they are infected. Accordingly, precautionary measures can be taken individually based on the persons' Covid-19 susceptibility. This paper introduces a Covid-19's Integrated Herd Immunity (CIHI) strategy. The aim of CIHI is to keep the society safe with the minimal losses even with the existence of Covid-19. This can be accomplished by two basic factors; the first is an accurate prediction of the cases who will be asymptomatic if they were infected by the virus, while the second is to take suitable precautions for those who are predicted to be badly affected by the virus even before the actual infection takes place. CIHI is realized through a new classification strategy called Distance Based Classification Strategy (DBCS) which classifies people based on their vulnerability to Covid-19 infection. The proposed DBCS classifies individuals into six different types, then suitable precautionary measures can be taken for every type. DBCS can also identify future symptomatic and asymptomatic cases. In fact, DBCS consists of three sequential phases, which are; (i) Outlier Rejection Phase (ORP) using Hybrid Outlier Rejection (HOR) method, (ii) Feature Selection Phase (FSP) using Hybrid Feature Selection (HFS) method, and (iii) Classification Phase (CP) using Accumulative K-Nearest Neighbors (AKNN). DBCS has been compared with recent Covid-19 diagnosing techniques based on “NileDS” dataset. Experimental results have proven the efficiency and applicability of the proposed strategy as it provides the best classification accuracy.
An optimization algorithm is a step-by-step procedure which aims to achieve an optimum value (maximum or minimum) of an objective function. Several natural inspired meta-heuristic algorithms have been inspired to solve complex optimization problems by utilizing the potential advantages of swarm intelligence. In this paper, a new nature-inspired optimization algorithm which mimics the social hunting behavior of Red Piranha is developed, which is called Red Piranha Optimization (RPO). Although the piranha fish is famous for its extreme ferocity and thirst for blood, it sets the best examples of cooperation and organized teamwork, especially in the case of hunting or saving their eggs. The proposed RPO is established through three sequential phases, namely; (i) searching for a prey, (ii) encircling the prey, and (iii) attacking the prey. A mathematical model is provided for each phase of the proposed algorithm. RPO has salient properties such as; (i) it is very simple and easy to implement, (ii) it has a perfect ability to bypass local optima, and (iii) it can be employed for solving complex optimization problems covering different disciplines. To ensure the efficiency of the proposed RPO, it has been applied in feature selection, which is one of the important steps in solving the classification problem. Hence, recent bio-inspired optimization algorithms as well as the proposed RPO have been employed for selecting the most important features for diagnosing Covid-19. Experimental results have proven the effectiveness of the proposed RPO as it outperforms the recent bio-inspired optimization techniques according to accuracy, execution time, micro average precision, micro average recall, macro average precision, macro average recall, and f-measure calculations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.